View in EDS HTML Full Text PDF Full Text

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.

Saved in:
Bibliographic Details
Title: Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.
Authors: He, Yonghan1 (AUTHOR), Khan, Sajid1 (AUTHOR), Huo, Zhiguang2 (AUTHOR), Lv, Dongwen1 (AUTHOR), Zhang, Xuan3 (AUTHOR), Liu, Xingui1 (AUTHOR), Yuan, Yaxia1 (AUTHOR), Hromas, Robert4 (AUTHOR), Xu, Mingjiang5 (AUTHOR), Zheng, Guangrong3 (AUTHOR), Zhou, Daohong1 (AUTHOR) zhoudaohong@cop.ufl.edu
Source: Journal of Hematology & Oncology. 7/27/2020, Vol. 13 Issue 1, p1-24. 24p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-020-00924-z